UB Paderborn / Katalog / Suche / in CDI

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

The lancet oncology, 2012-10, Vol.13 (10), p.983-992

2012

Volltextzugriff (PDF)

Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Trial TE08, ISRCTN56475197—The National Cancer Research Institute Testis Cancer Clinical Studies Group

Journal of clinical oncology, 2007-04, Vol.25 (11), p.1310-1315

2007

Volltextzugriff (PDF)

The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high‐dose chemotherapy as consolidation: a non‐cisplatin‐based induction approach

BJU international, 2016-03, Vol.117 (3), p.418-423

2016

Volltextzugriff (PDF)

18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22—The NCRI Testis Tumour Clinical Study Group

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3090-3095

2007

Volltextzugriff (PDF)

Paraneoplastic Cushing’s syndrome in prostate cancer: a difficult management problem

BJU international, 2008-02, Vol.101 (4), p.424-427

2008

Volltextzugriff (PDF)

TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status

BMC cancer, 2008-07, Vol.8 (1), p.191-191

2008

Volltextzugriff (PDF)

Headwinds to a Clean Energy Future: Nuisance Suits Against Wind Energy Projects in the United States

California law review, 2009-10, Vol.97 (5), p.1337-1375

Butler, Stephen Harland

2009

Volltextzugriff (PDF)

Electromotive drug delivery and bladder cancer

The lancet oncology, 2006, Vol.7 (1), p.6-7

Harland, Stephen J

2006

Volltextzugriff (PDF)

Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma

Expert opinion on drug delivery, 2008-01, Vol.5 (1), p.137-145

2008

Volltextzugriff (PDF)

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

The lancet oncology, 2015-01, Vol.16 (1), p.76-86

2015

Volltextzugriff (PDF)

Abiraterone and Increased Survival in Metastatic Prostate Cancer

The New England journal of medicine, 2011-05, Vol.364 (21), p.1995-2005

2011

Volltextzugriff (PDF)

Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients

European journal of cancer (1990), 2022-03, Vol.164, p.105-113

2022

Volltextzugriff (PDF)

Tumour markers for managing men who present with metastatic prostate cancer and serum prostate‐specific antigen levels of <10 ng/mL

BJU international, 2005-08, Vol.96 (3), p.303-307

2005

Volltextzugriff (PDF)

Chemotherapy for hormone-resistant prostate cancer: Where are we today?

Indian journal of urology, 2007-01, Vol.23 (1), p.55-60

2007

Volltextzugriff (PDF)

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/ml: The PSA negative patients

Cancer, 2003-12, Vol.98 (11), p.2362-2367

2003

Volltextzugriff (PDF)

Moving on after a serious untoward incident

Trends in urology & men's health, 2013-11, Vol.4 (6), p.33-36

Harland, Stephen

2013

Volltextzugriff (PDF)

The natural history of bone metastases in castrate-resistant prostate cancer

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.239-239

2014

Volltextzugriff (PDF)

Conundrum of the hereditary component of testicular cancer

The Lancet (British edition), 2000-10, Vol.356 (9240), p.1455-1456

Harland, Stephen J

2000

Volltextzugriff (PDF)

Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy

European journal of cancer (1990), 2013-11, Vol.49 (17), p.3648-3657

2013

Volltextzugriff (PDF)

Broad clinical activity of zoledronic acid in osteolytic to osteoblastic bone lesions in patients with a broad range of solid tumors

American journal of clinical oncology, 2002-12, Vol.25 (6 Suppl 1), p.S19-S24

2002

Volltextzugriff (PDF)

Split dose gemcitabine/ cisplatin (GC) in urothelial carcinoma of the bladder: Review of toxicity and response

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e16018-e16018

2016

Volltextzugriff (PDF)

Myocardial uptake of 99mTc-HDP and reduced perfusion on CT in subacute myocardial infarction

Clinical nuclear medicine, 2014-01, Vol.39 (1), p.e117-e120

2014

Volltextzugriff (PDF)

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma

Acta oncologica, 2013-06, Vol.52 (5), p.987-993

2013

Volltextzugriff (PDF)

The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours: A non-cisplatin-based regimen

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4529-4529

2012

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study

Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Trial TE08, ISRCTN56475197—The National Cancer Research Institute Testis Cancer Clinical Studies Group

The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high‐dose chemotherapy as consolidation: a non‐cisplatin‐based induction approach

18Fluorodeoxyglucose Positron Emission Tomography in the Prediction of Relapse in Patients With High-Risk, Clinical Stage I Nonseminomatous Germ Cell Tumors: Preliminary Report of MRC Trial TE22—The NCRI Testis Tumour Clinical Study Group

Paraneoplastic Cushing’s syndrome in prostate cancer: a difficult management problem

TGFbeta induces apoptosis and EMT in primary mouse hepatocytes independently of p53, p21Cip1 or Rb status

Headwinds to a Clean Energy Future: Nuisance Suits Against Wind Energy Projects in the United States

Electromotive drug delivery and bladder cancer

Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3–pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

Abiraterone and Increased Survival in Metastatic Prostate Cancer

Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients

Tumour markers for managing men who present with metastatic prostate cancer and serum prostate‐specific antigen levels of <10 ng/mL

Chemotherapy for hormone-resistant prostate cancer: Where are we today?

Clinical features of patients who present with metastatic prostate carcinoma and serum prostate-specific antigen (PSA) levels < 10 ng/ml: The PSA negative patients

Moving on after a serious untoward incident

The natural history of bone metastases in castrate-resistant prostate cancer

Conundrum of the hereditary component of testicular cancer

Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy

Broad clinical activity of zoledronic acid in osteolytic to osteoblastic bone lesions in patients with a broad range of solid tumors

Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial

Split dose gemcitabine/ cisplatin (GC) in urothelial carcinoma of the bladder: Review of toxicity and response

Myocardial uptake of 99mTc-HDP and reduced perfusion on CT in subacute myocardial infarction

Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma

The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours: A non-cisplatin-based regimen

Suchergebnisse filtern